The COVID-19 pandemic has highlighted a need for non-invasive, remote approaches to patient care. Dr. Eric Grigsby, CEO and Founder of Neurovations, and Ana Maiques, CEO and Co-founder of Neuroelectrics, […]
Episode 29: Low Back Pain – Part 1 Dr. Ramchandani discusses the basics of low back pain. Bonus: some good news about COVID-19 research.
Episode 28: Prostate Cancer Dr. Ramchandani discusses the incidence and death rate of Prostate cancer. What you can do to prevent it? How to stay healthy, active, and eat right. […]
What does it really take to get that big idea to market? Entrepreneurs Eric Grigsby, MD, MBA, CEO and Founder of Neurovations, and David Caraway, MD PhD, CMO from Nevro […]
CEO and Founder of Neurovations, Dr. Eric Grigsby, and Co-founder and Director of Research at Millennium Pain Center, Dr. Ricardo Vallejo joined up for a deep dive into how a […]
Rocca Family Vineyards hosts mobile COVID-19 testing in the parking lot.
N3 Laboratories is proud to offer Serology (Antibody) testing for COVID-19
HF10® is a next-generation spinal cord stimulation (SCS) system offering a wide range of benefits: -HF10 has demonstrated significant relief for both back and leg pain.¹ -HF10 can be left […]
CEO and Founder of Neurovations Dr. Eric Grigsby and Chief Medical Officer of Setpoint Dr. David Chernoff met for an in-depth discussion on the activation of neuroimmune reflexes by Vagus […]
CEO and Founder of Neurovations, Dr. Eric Grigsby joined Professor and Director of Neuromodulation Services at UCSF, Dr. Lawrence Poree, for an in-depth conversation on equity and inclusion in pain management.
The Patient Registry of Intrathecal Ziconotide Management evaluated the long-term effectiveness and safety of intrathecal ziconotide.
CEO and Founder of Neurovations and Eric J. Grigsby, MD, MBA and Peter Staats, MD, MBA met recently for a conversation exploring Neuromodulation for the COVID-19 Cytokine Storm.